Trials / Completed
CompletedNCT01314079
Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula
Follow-up Study to Evaluate the Sustained Efficacy and Safety for the Patients With Adipoplus Injected in Phase II Clinical Trials(ANTG-ASC-202)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Anterogen Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open follow-up clinical trials to evaluate a sustained efficacy and safety of Adipoplus inj. for 10 months (12 months after final dose injection)after Phase II clinical trial.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2011-03-14
- Last updated
- 2016-11-23
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01314079. Inclusion in this directory is not an endorsement.